Patents by Inventor Jens Werner Eckstein

Jens Werner Eckstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclosporins for the treatment of immune disorders
    Patent number: 7012064
    Abstract: The present invention relates to methods of treating or preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically acceptable carrier or excipient: in Formula (I), the formula for residue A is:
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: March 14, 2006
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Tsvetelina Lazarova, Jens Werner Eckstein
  • Cyclosporins for the treatment of immune disorders
    Patent number: 6979671
    Abstract: The present invention relates to a cyclosporin analog of the following formula (I) or its pro-drug or pharmaceutically acceptable salt: In formula I, the formula for residue A is: where X and Y are defined according to the claimed invention the present invention also relates to pharmaceutical compositions comprising pro-drugs or pharmaceutically acceptable salts of the compounds of the present invention and the use thereof for treating an inflammatory or immune disorder in a subject need of such treatment.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: December 27, 2005
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Tsvetelina Lazarova, Jens Werner Eckstein
  • &agr;-hydroxyarylbutanamine inhibitors of aspartyl protease
    Patent number: 6696494
    Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: February 24, 2004
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Guoqiang Wang, John Rougas, Jude Elizabeth Mathews, Kate Ryan Muldoon, Vincent Alfred Boyd, Jens Werner Eckstein, Steven Wayne Riesinger
  • Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
    Publication number: 20030207934
    Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Application
    Filed: October 22, 2001
    Publication date: November 6, 2003
    Inventors: Yat Sun Or, Guoqiang Wang, John Rougas, Jude Elizabeth Mathews, Kate Ryan Muldoon, Vincent Alfred Boyd, Jens Werner Eckstein, Steven Wayne Riesinger
  • Cyclosporins for the treatment of immune disorders
    Publication number: 20030186855
    Abstract: The present invention relates to methods of treating or preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically acceptable carrier or excipient: 1
    Type: Application
    Filed: January 23, 2003
    Publication date: October 2, 2003
    Inventors: Yat Sun Or, Tsvetelina Lazarova, Jens Werner Eckstein
  • Cyclosporins for the treatment of immune disorders
    Publication number: 20030166515
    Abstract: The present invention relates to methods of treating or preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically-acceptable carrier or excipient: 1
    Type: Application
    Filed: January 23, 2003
    Publication date: September 4, 2003
    Inventors: Yat Sun Or, Tsvetelina Lazarova, Jens Werner Eckstein